Bernstein Harold sold $270K of MAZE
Bernstein Harold (President, R&D & CMO) sold 10,295 shares of Maze Therapeutics, Inc. (MAZE) at an average of $26.24 ($25.78–$27.12, $0.27M total) across 4 trades over 2026-09-02 to 2026-09-03.
How this was made
The 30-second read
Why it matters
Insider sell of $270K by a senior executive may influence short-term sentiment.
Market read
Provides fresh data on insider activity for MAZE, useful for short-term traders.
What to watch
No 10b5-1 plan; timing may be unrelated to company fundamentals.
Background
SEC Form 4 filing discloses insider transactions.
Ticker impact
President of R&D & CMO sold 10,295 shares for $270,110.80 in a Form 4 filing.
Potential short-term downward pressure on MAZE stock.
The sale size is modest but involves a senior executive; markets often react negatively to insider sells.
Market effects
May raise concerns in biotech R&D leadership stability.
Limited to US biotech investors.
Low global impact.
Counterpoint
Sale could be routine portfolio diversification, not a negative signal.
Key entities
- personBernstein Harold
President, R&D & CMO of Maze Therapeutics